Study of the Effects of Time-Restricted Feeding on the Immune Function of Individuals With Obesity
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Mar 26, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients with obesity
- • Women
- • Age 18-64 years
- • Body mass Index between 40-50 kg/m²
- • Scheduled bariatric surgery 10-12 weeks after the nutritional intervention
- • Self-reported eating pattern window of more than 14h
- • Three meal eating pattern
- • Stable body weight (less than 10% of current body weight during the last 3 months)
- • Patients who have a favourable decision from the multidisciplinary team meetings after multidisciplinary nutritional follow-up of at least 6 months and history of failure with non-surgical weight loss methods
- • Social security affiliation
- • Written consent
- • Good understanding of the French language
- • Lean patients
- • Women
- • Age 18-64 years
- • Body mass Index between 18.5-24.9 kg/m²
- • Scheduled banal surgery in the opinion of the investigator
- • Self-reported eating pattern window of more than 14h
- • Social security affiliation
- • Written consent
- • Good understanding of the French language
- Exclusion Criteria:
- • Diabetes type I or II
- • Major cardiovascular disease
- • Pregnancy
- • Medication that could affect the study outcomes (i.e. anti-inflammatory drugs, antibiotics, immunosuppressors)
- • Use products intended for weight loss
- • Night work shift
- • Past record of malignant tumors
- • Serious liver dysfunction or chronic kidney disease
- • Eating disorders
- • Chronic viral disease (Hepatitis B or C, HIV) or inflammatory systemic diseases (i.e. Crohn's disease, rheumatoid arthritis)
- • Serious cardiovascular or cerebrovascular disease within 6 months before randomization
- • Severe gastrointestinal diseases or gastrointestinal surgery in the 12 months before randomization
- • Under guardianship, curatorship, deprived of liberty
- • Unable or unwilling to sign the informed consent form.
- • Patient on AME (state medical aid)
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Paris, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Related Blog Entries
View all
